Nippon India Nifty Pharma ETF - Growth Plan vs PGIM India Healthcare Fund Regular Plan - IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  PGIM India Healthcare Fund Regular Plan - IDCW Reinvestment | |
|---|---|---|
| NAV | ₹27.1122 | ₹12.18 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +21.80% |
| 3 year (p.a.) | +20.35% | +12.32% |
| 5 year (p.a.) | +14.55% | +12.32% |
| Expense ratio | 0.18% | 2.47% |
| Fund size | ₹1,622.31 Cr | ₹95.49 Cr |
| Risk | Very high | — |
| Category | Etfs | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.